Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN87,9187,921,00
Msft0,17
Nokia4,2464,422,72
IBM-1,50
Mercedes-Benz Group AG53,6553,67-2,92
PFE-2,25
09.10.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 08.10.2025
Celsius (NASDAQ Cons)
Závěr k 8.10.2025 Změna (%) Změna (USD) Objem obchodů (ks)
62,91 3,03 1,85 5 034 088
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.10.2025
Popis společnosti

Business Summary: Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Celsius Holdings Inc revenues increased 41% to $1.07B. Net income applicable to common stockholders decreased 9% to $120.1M. Revenues reflect BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS segment increase from $402M to $1.07B, North America segment increase from $382.4M to $1.02B, Europe segment increase from $16.7M to $37M, Asia segment increase from $860K to $6.6M.



  • Poslední aktualizace: 09.10.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorJesse Shefferman5330.01.2023
Chief Financial OfficerPatrick Fabbio5730.01.202330.01.2023
Chief Scientific Operations OfficerJacqueline Zummo4401.01.2021
ControllerHannah Fry35
Chief Commercial OfficerWilliam Conkling-02.06.202502.06.2025
Chief Medical OfficerLeonardo Nicacio4715.04.202515.04.2025